Cited 1 times in
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도영 | - |
dc.date.accessioned | 2018-07-20T08:41:39Z | - |
dc.date.available | 2018-07-20T08:41:39Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1976-2283 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/161363 | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Editorial Office of Gut and Liver | - |
dc.relation.isPartOf | GUT AND LIVER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Antiviral Agents/economics* | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Hepatitis C, Chronic* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Ribavirin/economics | - |
dc.title | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Internal Medicine | - |
dc.contributor.googleauthor | Do Young Kim | - |
dc.identifier.doi | 10.5009/gnl17408 | - |
dc.contributor.localId | A00385 | - |
dc.relation.journalcode | J00954 | - |
dc.identifier.eissn | 2005-1212 | - |
dc.identifier.pmid | 29081211 | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.affiliatedAuthor | Kim, Do Young | - |
dc.citation.volume | 11 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 745 | - |
dc.citation.endPage | 746 | - |
dc.identifier.bibliographicCitation | GUT AND LIVER, Vol.11(6) : 745-746, 2017 | - |
dc.identifier.rimsid | 61281 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.